Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-03-15 @ 10:45 AM
Study NCT ID:
NCT01217957
Status:
COMPLETED
Last Update Posted:
2018-03-14
First Post:
2010-09-24
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-09-24
First Submit QC Date:
None
Study First Post Date:
2010-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-12-04
Results First Submit QC Date:
None
Results First Post Date:
2016-01-27
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-12
Last Update Post Date:
2018-03-14
Last Update Post Date Type:
ACTUAL